β-blocker therapy and depression [1] (multiple letters)

Journal of the American Medical Association

Volumn 288, Issue 15, 2002, Pages 1845-1846

  Terao, Takeshi ^a   Messerli, Franz H ^b   Grossman, Ehud ^c   Ko, Dennis T ^d   Hebert, Patricia R ^d   Curtis, Jeptha P ^d   Krumholz, Harlan M ^d   Coffey, Christopher S ^e  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; PINDOLOL; PLACEBO;

CHEMICALLY INDUCED DISORDER; DEPRESSION; FATIGUE; HUMAN; NOTE; SEXUAL DYSFUNCTION; SUICIDE; HYPERTENSION; RISK; ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; LETTER; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STROKE;

ADRENERGIC BETA-ANTAGONISTS; DEPRESSION; FATIGUE; HUMANS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SUICIDE; HYPERTENSION; RISK;

EID: 0037120866     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)